Introduction
============

Human cervical mucus is known to select viable spermatozoa in the due course of normal and healthy pregnancies, acting as a natural barrier against non-viable spermatozoa. However, this process of natural selection is bypassed in assisted reproductive technology (ART) programs. Consequently, it is very important to develop high-quality procedures for the removal of seminal plasma in order to prepare and select of normal, healthy sperm for ART treatment.

Human ejaculate is composed of several components in addition to sperm, such as seminal liquid, epithelial cells, immature and necrotic sperm cells, and blood cells. Bacteria are also found in some patient samples. These components are involved in the production of toxic or bioactive substances such as decapacitation factors and free oxygen radicals that may impair the fertilization rate of the egg \[[@B1],[@B2]\]. For this reason, removing the sperm from seminal fluid is a very important step in ART procedures \[[@B3]\]. More recently, it has been reported that fertilization with unselected apoptotic spermatozoa may contribute to failures in ART cycles \[[@B4]\]. Sperm DNA fragmentation is increased in poor-quality semen samples and is correlated with failed fertilization, impaired preimplantation development, and less frequent pregnancy outcomes \[[@B5],[@B6]\]. An effective sperm separation method is therefore required for ART treatments to be successful.

Many methods have been developed for separating human spermatozoa from seminal plasma, including the swim-up (SUP) method, self-migration sedimentation, glass wool filtration, magnetic-activated cell sorting (MACS), and the use of a density gradient medium \[[@B4]\]. Among these methods, the methods that are most commonly applied in ART therapy are SUP and discontinuous density gradient centrifugation (DGC) using silane-coated colloidal silica particles in suspension.

It also has been shown that diluting the semen sample with a medium can improve sperm function and enhance the chances of fertilization. It has been suggested that media composed of HEPES, bicarbonate, calcium, and magnesium may enhance the chances of successful fertilization \[[@B7],[@B8],[@B9],[@B10],[@B11],[@B12]\]. Both the complex Ham\'s F-10 medium and a simple medium composed of modified human tubal fluid are currently used for washing human sperm in clinical settings \[[@B13],[@B14]\]. Some researchers have suggested that the use of these media results in higher-quality sperm, and improved ART outcomes have been reported with the use of either sperm selection or dilution. Recently, HEPES-buffered modified human tubal fluid has been developed and is commercially available as sperm washing medium (SWM).

No study has yet reported data comparing the clinical outcomes that result from the use of Ham\'s F-10 medium and SWM. Therefore, in this study, we studied the effects of these two different media in combination with the density-gradient centrifugation/swim-up (DGC-SUP) and the SUP sperm preparation methods, in order to determine the best SWM and processing methods for ART treatment by comparing clinical outcomes, with a focus on IVF pregnancy rates and associated metrics.

Methods
=======

1. Experimental design, patients and inclusion criteria
-------------------------------------------------------

We retrospectively evaluated 429 cycles performed from November 2012 to March 2013. The inclusion criteria were as follows: regular menstrual cycles of 25-35 days, baseline follicle-stimulating hormone levels \<15 IU/L, anti-Müllerian hormone levels ≥1.0 ng/mL, the presence of both ovaries and an intact uterus, and the absence of polycystic ovaries. Couples were excluded from this study if the female partner was over 40 years old or had poor ovarian function (less than three matured oocytes in a stimulation cycle), and if the male partner had undergone testicular sperm extraction or had a low total sperm count (\<5×10^6^/mL). No patient had received any hormone therapy for at least 60 days preceding the study.

We assigned the couples into four groups according to the media and techniques used for sperm preparation: DGC-SUP with Ham\'s F-10 medium (group 1, n=82), DGC-SUP with SWM (group 2, n=43), SUP with Ham\'s F-10 medium (group 3, n=181) and SUP with SWM (group 4, n=123). The couples\' semen samples were evaluated according to the World Health Organization\'s 1999 criteria for whether *in vitro* fertilization (IVF) is indicated, and intracytoplasmic sperm injection (ICSI) was performed in couples who had low sperm concentration, motility, or quality, or who had experienced low or failed fertilization in previous IVF cycles.

2. Semen sample collection and preparation
------------------------------------------

All semen samples were collected by masturbation after two to seven days of ejaculatory abstinence. After liquefaction for 20-30 minutes at room temperature, the semen samples were evaluated. The decision of performing DGC-SUP or SUP was made based on the quality of the semen sample. DGC-SUP was performed when the semen sample had low motility (\<50% motility count), high viscosity with elevated leukocytes (over 2×10^6^/mL; LeucoScreen, Bioscreen, Torrance, CA, USA), or a high level of debris. All other semen samples were prepared using the SUP method.

3. DGC/SUP method
-----------------

Discontinuous DGC was performed using a sterile pipette. The lower layer (90% Isolate, Irvine Scientific, Santa Ana, CA, USA) was first transferred into a conical centrifuge tube. Using a new sterile pipette, the upper layer (50% Isolate, Irvine Scientific) was gently dispensed on top of the lower layer. A liquefied 2.0 mL semen sample was then placed on top of the upper layer and the tube was centrifuged for 10 minutes at 300 g. This process was repeated using additional tubes until the entire sample of ejaculate was processed. The upper and lower layers were carefully aspirated without disturbing the pellet and discarded. Using a transfer pipette, 4.0 mL of Ham\'s F-10 medium (Irvine Scientific) with 0.5% synthetic serum substitute (Irvine Scientific) or 4.0 mL of HEPES-buffered SWM (Irvine Scientific) was added onto the pellet and the resuspended pellet was centrifuged for five minutes at 250 g. The washing procedure was repeated twice. The supernatant was then removed and the pellet was suspended in 0.5 mL of Ham\'s F-10 medium or SWM, which was gently layered on top of the pellet, and the tube was inclined at an angle of 45 degrees and incubated at 35℃ for at least 30-40 minutes. After the incubation period, a sterile pipette was used to aspirate the supernatant and transfer it to a sterile 5-mL conical tube. Sperm count and motility were determined in the recovered fractions ([Figure 1](#F1){ref-type="fig"}).

4. SUP method
-------------

In groups 3 and 4, the semen sample was washed in a 15-mL Corning tube (Corning incorporated Life Science, New York, NY, USA) with 4 mL of Ham\'s F-10 medium supplemented with 0.5% synthetic serum substitute, or with 4 mL of SWM, and centrifuged at 250 g for five minutes. The washing procedure was repeated twice. The supernatant was discarded and 0.5 mL of medium was gently layered on top of the sperm pellet to allow motile sperm to swim up. The tube was then inclined at an angle of 45 degrees and incubated at 35℃ for at least 30-40 minutes. After the incubation period, a sterile pipette was used to aspirate the supernatant and transfer it to a sterile 5-mL conical tube. Sperm count and motility were estimated.

5. Medium
---------

SWM is a modified form of human tubal fluid, and Ham\'s F-10 medium is supplemented with proteins. The composition of each medium used in this study is summarized in [Table 1](#T1){ref-type="table"}.

6. Ovarian stimulation, oocyte retrieval, and embryo transfer
-------------------------------------------------------------

Patients were subjected to ovarian stimulation with the use of gonadotropins (follicle-stimulating hormone or human menopausal gonadotropin) and gonadotropin-releasing hormone analogues or antagonists were used for controlled ovarian hyperstimulation. Patients received human chorionic gonadotropin when the diameter of the two or three leading follicles was \>18 mm. Ultrasound-guided oocyte retrieval was performed 36 hours after the human chorionic gonadotropin injection, and luteal support consisting of vaginally administered progesterone was provided.

The insemination procedure performed on the oocytes was conventional IVF, ICSI, or split IVF-ICSI. We decided on ICSI or split IVF-ICSI to minimize or eliminate fertilization failure in couples who were in their first cycle or for whom one year had elapsed after IVF ([Table 2](#T2){ref-type="table"}). Approximately 16-20 hours after the procedure, fertilization was confirmed by the presence of two pronuclei and the extrusion of the second polar body. The embryos were cultured in 2 mL of culture medium (Quinn\'s Advantage Cleavage Medium, SAGE, Trumbull, CT, USA) supplemented with 20% synthetic protein substitute (SAGE, Trumbull, CT, USA) in a humidified atmosphere with 6% CO~2~ at 37℃ for three days. Embryo transfer was performed on day three of development, using a soft catheter with transabdominal ultrasound guidance. One to three embryos were transferred per patient. A pregnancy test was performed 13 days after embryo transfer. All women with a positive test underwent a transvaginal ultrasound scan two weeks after the positive test.

7. Statistical analysis
-----------------------

The data were expressed as mean±standard deviation. The student\'s *t*-test was used. A *p*-value \<0.05 was considered to indicate statistical significance.

Results
=======

The sperm parameters in the four groups are summarized in [Table 3](#T3){ref-type="table"}. The initial progressive motility of the sperm before treatment was lower in the DGC-SUP groups than in the SUP groups, but there were no differences in the morphology (assessed using the strict morphology approach), initial volume, final volume, and count.

Patient characteristics such as mean age, infertility duration, number of previous IVF cycles, fertilization, embryo transfer, and pregnancy rates are summarized in [Table 4](#T4){ref-type="table"}. No differences among the four groups were observed regarding the age of the male and female partner, the duration of infertility, and the number of previous IVF cycles. There was no significant difference in the female partner\'s basal levels of follicle-stimulating hormone and anti-Müllerian hormone among groups (data not shown). Regarding the causes of infertility, 207 of 429 patients (48.3%) had unexplained fertility, 127 (29.6%) had infertility with a complex cause associated with the female partner, 62 (14.5%) had tubal factor infertility and 39 (9%) had male factor infertility. The patients with male factor infertility had lower than normal sperm counts, but did not suffer from conditions that would have caused them to meet the exclusion criteria outlined in the methods. Again, no significant differences were found among the four groups.

The clinical outcomes were not significantly different between the DGC-SUP and SUP groups with regard to all parameters, including the number of retrieved oocytes and the fertilization rates of both conventional IVF and ICSI treatment. The four groups also had a similar number and frequency of embryos that were transferred on day three. No clinical results exhibited a statistically significant difference among the four groups.

The presence of similar clinical outcomes among the four groups suggest that the four methods of preparing sperm that we studied led to comparable fertilization rates, as well as embryos of comparable quality and developmental potential.

Discussion
==========

Immediately after ejaculation, sperm are not able to participate in fertilization. Instead, they obtain this ability while passing through the female reproductive organs. Significant advances have recently been made in understanding the molecular mechanisms involved in certain aspects of capacitation and the acrosome reaction associated with the egg-sperm fusion process \[[@B7]\]. Moreover, abnormal sperm parameters such as extremely low sperm concentration, poor sperm motility, and abnormal morphology contribute to low fertility \[[@B15]\].

Spermatozoa are protected by various materials in the seminal plasma itself. However, materials such as seminal liquid, epithelial cells, immature and necrotic sperm cells, red blood cells, white blood cells, and even bacteria can produce toxic or bioactive substances, such as decapacitation factors or free oxygen radicals that can impair the capacity of the sperm to fertilize the egg. For this reason, washing the sperm is necessary to improve their function.

Separation of the sperm from the whole semen is an important and necessary step. Various semen preparation techniques have been developed in ART programs to isolate motile, morphologically normal, and healthy spermatozoa for use in IVF. A number of sperm washing techniques can be used to separate motile sperm from nonmotile or dead sperm as well as other contaminating cell debris. The DGC-SUP and SUP methods are two of the most widely used techniques in semen preparation \[[@B16]\]. The most commonly used methods are the simple washing of spermatozoa, which is based on self-migration of the spermatozoa, and the SUP and DGC-SUP methods, in which preparations with different density gradients are used. SUP from a washed pellet is easy to perform and cost-effective. It is the oldest and most commonly used sperm separation method, and is therefore used in many IVF laboratories around the world \[[@B17]\]. However, the DGC-SUP method improves success rates in intrauterine insemination cycles \[[@B18]\], and has an increased ability to concentrate normal sperm \[[@B16]\] in comparison with the SUP method. It has been reported that the DGC-SUP method has comparable results to the electrophoretic method for sperm recovery, motility, and DNA fragmentation \[[@B19]\].

The presence of DNA damage within spermatozoa is negative associated with fertilization, cleavage, blastulation, implantation, and pregnancy \[[@B15],[@B20]\]. Xue et al. \[[@B21]\] reported that DGC-SUP led to the enrichment of sperm with normal morphology and intact DNA in teratozoospermic patients. The effect of sperm DNA fragmentation on pregnancy was not affected by the processing technique used to separate the sperm from the whole semen sample or the fertilization procedure, as measured both before and after SUP. It is difficult to determine how sperm DNA fragmentation affects clinical outcomes; while the DNA integrity of sperm can be evaluated, the repair capacity of oocytes remains an enigma \[[@B21],[@B22],[@B23]\]. Stevanato et al. \[[@B24]\] have suggested that semen processing by DGC-SUP is not generally useful in selecting sperm with higher double-strand DNA integrity. However, both DGC-SUP and SUP methods allow a healthy sperm population with a low percentage of apoptotic sperm to be obtained \[[@B25]\]. In addition, Borges et al. \[[@B26]\] reported that both the DGC-SUP and SUP methods were useful in recovering sperm with improved characteristics, and they obtained similar IMSI outcomes using these two methods. In this study, the sample number of DGC-SUP groups was smaller than the SUP groups, because the DGC-SUP method was used to treat semen samples with \<50% motility, highly elevated leukocytes, or high levels of debris. Nonetheless, we could not find any significant differences in the clinical results of the four sperm preparation techniques we used.

Various materials exist to enhance the competence of sperm. In particular, bicarbonate in seminal plasma stimulates adenylate cyclase in spermatozoa, and the bicarbonate-sensitive adenylate cyclase system has been shown to regulate sperm motility \[[@B10]\]. Calcium is an essential bivalent cation for the acrosome reaction, and extracellular calcium is also required for the sperm capacitation process \[[@B11]\]. Proteins and magnesium are also responsible for chromatin stability in sperm, motility, and the acrosome reaction \[[@B27],[@B28]\]. Murase et al. \[[@B9]\] reported that albumin and HEPES are beneficial for the long-term storage of boar sperm. In this experiment, we compared the use of a complex culture medium that was traditionally used in early ART programs (Ham\'s F-10 medium), with the use of a simple medium that has recently been used in IVF programs for semen washing (SWM). HEPES is specifically contained in SWM. However, in this study, we did not find any difference in clinical outcomes among the four different combinations of the two media and the two SUP methods. Therefore, our results suggest that flexibility is appropriate in the choice of a medium or method for sperm preparation in ART programs, and we propose that there is no need to use expensive IVF culture media such as SWM.
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![Schematic diagram for preparing sperm with the density gradient centrifugation-swim-up (DGC-SUP) and swim-up (SUP) methods using Ham\'s F-10 medium and sperm washing medium (SWM). WBC, white blood cell; HPF, high power field; SSS, synthetic serum substitute.](cerm-42-22-g001){#F1}

###### Composition of Ham\'s F-10 medium and sperm washing medium

![](cerm-42-22-i001)

HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; SWM, sperm washing medium; SSR, synthetic serum substitute.

###### Number of cycles performed using each of the different fertilization procedures

![](cerm-42-22-i002)

DGC-SUP, density gradient centrifugation/swim-up; SUP, swim-up; SWM, sperm washing medium; IVF, *in vitro* fertilization; ICSI, intra cytoplasmic sperm injection.

###### Comparison of semen parameters in the four groups

![](cerm-42-22-i003)

Values are presented as mean±standard deviation.

DGC-SUP, density gradient centrifugation/swim-up; SUP, swim-up; SWM, sperm washing medium; Strict morphology was carried out according to the 1999 World Health Organization criteria.

###### Comparison of clinical outcomes in the four groups

![](cerm-42-22-i004)

Values are presented as mean±standard deviation or number (%).

DGC-SUP, density gradient centrifugation/swim-up; SUP, swim-up; SWM, sperm washing medium; IVF, *in vitro* fertilization; 2PN, two pronuclei; ICSI, intra cytoplasmic sperm injection.

^a)^Fertilization rate: number of 2PN instances.
